Does Ubs own EIGR stock?

As of its Q4 2023 13F, Ubs held 11,045 shares of EIGR (Eiger Biopharmaceuticals), worth $2,485.

How many shares of EIGR does Ubs own?

As of its Q4 2023 13F, Ubs held 11,045 shares of EIGR (Eiger Biopharmaceuticals).

As of its Q4 2023 13F, Ubs' EIGR position was worth $2,485.

Ubs already held EIGR in its Q1 2019 13F, the earliest on record, and listed it in 20 quarterly 13F filings.

Position history for UBS Group AG's holdings in EIGER BIOPHARMACEUTICALS INC

Final Value

Final Shares

Total Value Change

-$7,000

Total Shares Change

-505

Quarter-by-Quarter History

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2024-Q1 Latest	Exited	0	-100.0%	$0	0.0%	—	0
2023-Q4	Increased	11,045	+193x	$2,485	0.0%	—	14
2023-Q3	Increased	57	+1040.0%	$18	0.0%	—	12
2023-Q2	Decreased	5	-100.0%	$4	0.0%	—	0
2023-Q1	Decreased	13,597	-14.2%	$12,197	0.0%	—	0
2022-Q4	Increased	15,850	+223.6%	$18,703	0.0%	—	20
2022-Q3	Decreased	4,898	-25.7%	$37,000	0.0%	—	0
2022-Q2	Decreased	6,593	-50.1%	$42,000	0.0%	—	0
2022-Q1	Increased	13,209	+0.9%	$110,000	0.0%	—	15
2021-Q4	Increased	13,086	+245.6%	$68,000	0.0%	—	23
2021-Q3	Increased	3,786	+62.7%	$25,000	0.0%	—	19
2021-Q2	Decreased	2,327	-4.8%	$20,000	0.0%	—	0
2021-Q1	Decreased	2,443	-97.2%	$22,000	0.0%	—	0
2020-Q4	Increased	88,087	+10.6%	$1.1M	0.0%	—	28
2020-Q3	Decreased	79,669	-11.3%	$648,000	0.0%	—	0
2020-Q2	Increased	89,785	+31.1%	$862,000	0.0%	—	32
2020-Q1	Increased	68,481	+150.5%	$466,000	0.0%	—	39
2019-Q4	Increased	27,341	+59.8%	$407,000	0.0%	—	34
2019-Q3	Increased	17,111	+3288.3%	$175,000	0.0%	—	36
2019-Q2	Unchanged	505	0.0%	$5,000	0.0%	—	0
2019-Q1	First report	505	-	$7,000	0.0%	—	0

Other major holders of EIGR: AMERIPRISE FINANCIAL INC